177 related articles for article (PubMed ID: 19840778)
1. Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.
Duncan GE; Inada K; Koller BH; Moy SS
Brain Res; 2010 Jan; 1307():166-76. PubMed ID: 19840778
[TBL] [Abstract][Full Text] [Related]
2. Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.
Duncan GE; Inada K; Farrington JS; Koller BH
Brain Res; 2008 Jul; 1221():41-8. PubMed ID: 18550035
[TBL] [Abstract][Full Text] [Related]
3. Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function.
Duncan GE; Koller BH; Moy SS
Brain Res; 2012 Mar; 1443():98-105. PubMed ID: 22297176
[TBL] [Abstract][Full Text] [Related]
4. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction.
Miyamoto S; Snouwaert JN; Koller BH; Moy SS; Lieberman JA; Duncan GE
Neuropsychopharmacology; 2004 Dec; 29(12):2180-8. PubMed ID: 15467708
[TBL] [Abstract][Full Text] [Related]
6. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
Duncan GE; Moy SS; Lieberman JA; Koller BH
Pharmacol Biochem Behav; 2006 Nov; 85(3):481-91. PubMed ID: 17097724
[TBL] [Abstract][Full Text] [Related]
7. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Lieberman JA; Koller BH
Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
[TBL] [Abstract][Full Text] [Related]
8. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH
Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649
[TBL] [Abstract][Full Text] [Related]
9. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
Halene TB; Ehrlichman RS; Liang Y; Christian EP; Jonak GJ; Gur TL; Blendy JA; Dow HC; Brodkin ES; Schneider F; Gur RC; Siegel SJ
Genes Brain Behav; 2009 Oct; 8(7):661-75. PubMed ID: 19563516
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Moy SS; Perez A; Koller BH; Duncan GE
Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
[TBL] [Abstract][Full Text] [Related]
11. Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress.
Duncan GE; Inada K; Farrington JS; Koller BH; Moy SS
Brain Res; 2009 Apr; 1265():186-95. PubMed ID: 19232330
[TBL] [Abstract][Full Text] [Related]
12. Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.
Bodarky CL; Halene TB; Ehrlichman RS; Banerjee A; Ray R; Hahn CG; Jonak G; Siegel SJ
J Pharmacol Exp Ther; 2009 Oct; 331(1):308-18. PubMed ID: 19602553
[TBL] [Abstract][Full Text] [Related]
13. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam.
Baran H; Löscher W; Mevissen M
Brain Res; 1994 Aug; 652(2):195-200. PubMed ID: 7953730
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists.
Eriksson C; Zou LP; Ahlenius S; Winblad B; Schultzberg M
Brain Res Mol Brain Res; 2000 Dec; 85(1-2):103-13. PubMed ID: 11146112
[TBL] [Abstract][Full Text] [Related]
15. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
Chen HH; Stoker A; Markou A
Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
[TBL] [Abstract][Full Text] [Related]
16. In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus.
Ogita K; Okuda H; Watanabe M; Nagashima R; Sugiyama C; Yoneda Y
Neuropharmacology; 2005 May; 48(6):810-21. PubMed ID: 15829253
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
18. Knockdown and overexpression of NR1 modulates NMDA receptor function.
Kalev-Zylinska ML; Symes W; Young D; During MJ
Mol Cell Neurosci; 2009 Aug; 41(4):383-96. PubMed ID: 19394426
[TBL] [Abstract][Full Text] [Related]
19. Participation of NMDA and kainate receptors of paraventricular nucleus in cardiovascular responses to glutamate receptor agonist.
Gören MZ; Onat F; Berkman K
Eur J Pharmacol; 2000 Jan; 388(1):77-84. PubMed ID: 10657549
[TBL] [Abstract][Full Text] [Related]
20. Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function.
Bickel S; Lipp HP; Umbricht D
Neuropsychopharmacology; 2008 Jun; 33(7):1680-9. PubMed ID: 17712349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
